Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 15
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving the most endangered seabird in the Americas

    Seven years of intense field monitoring and automated recordings, showed us which factors negatively impact...

    A non-invasive way to track the fluffy yellow-bellied gliders of North Queensland, Australia

    The Yellow-bellied glider (YBG) is a unique animal that glides between trees of woodlands in North-eastern...

    Backer Badge Funded